These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16428739

  • 1. Interleukin 1alpha increases the susceptibility of rabbits to experimental viridans streptococcal endocarditis.
    Dankert J, van der Werff J, Joldersma W, Zaat SA.
    Infect Immun; 2006 Feb; 74(2):947-52. PubMed ID: 16428739
    [Abstract] [Full Text] [Related]

  • 2. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis.
    Dankert J, Krijgsveld J, van Der Werff J, Joldersma W, Zaat SA.
    J Infect Dis; 2001 Sep 01; 184(5):597-605. PubMed ID: 11494165
    [Abstract] [Full Text] [Related]

  • 3. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.
    Dankert J, van der Werff J, Zaat SA, Joldersma W, Klein D, Hess J.
    Infect Immun; 1995 Feb 01; 63(2):663-71. PubMed ID: 7822036
    [Abstract] [Full Text] [Related]

  • 4. Effects of oral flora on platelets: possible consequences in cardiovascular disease.
    Herzberg MC, Meyer MW.
    J Periodontol; 1996 Oct 01; 67(10 Suppl):1138-42. PubMed ID: 8910832
    [Abstract] [Full Text] [Related]

  • 5. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
    Hsu RB, Lin FY.
    Cardiology; 2006 Oct 01; 105(4):234-9. PubMed ID: 16534200
    [Abstract] [Full Text] [Related]

  • 6. Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.
    Anguita-Alonso P, Rouse MS, Piper KE, Steckelberg JM, Patel R.
    Antimicrob Agents Chemother; 2006 Apr 01; 50(4):1263-7. PubMed ID: 16569838
    [Abstract] [Full Text] [Related]

  • 7. Type IV Pili of Streptococcus sanguinis Contribute to Pathogenesis in Experimental Infective Endocarditis.
    Martini AM, Moricz BS, Woods LJ, Jones BD.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0175221. PubMed ID: 34756087
    [Abstract] [Full Text] [Related]

  • 8. Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis.
    Yokota M, Basi DL, Herzberg MC, Meyer MW.
    Microbiol Immunol; 2001 Dec 22; 45(10):699-707. PubMed ID: 11762752
    [Abstract] [Full Text] [Related]

  • 9. [Oral streptococci: implications in infectious pathology].
    Băncescu G, Băncescu A.
    Bacteriol Virusol Parazitol Epidemiol; 2003 Dec 22; 48(2-3):99-105. PubMed ID: 15341322
    [No Abstract] [Full Text] [Related]

  • 10. [Oral streptococci: factors and mechanisms of pathogenicity (part II)].
    Băncescu G, Băncescu A.
    Bacteriol Virusol Parazitol Epidemiol; 2003 Dec 22; 48(2-3):93-8. PubMed ID: 15341321
    [No Abstract] [Full Text] [Related]

  • 11. Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.
    Teles C, Smith A, Lang S.
    Antimicrob Agents Chemother; 2012 Jan 22; 56(1):458-63. PubMed ID: 22037854
    [Abstract] [Full Text] [Related]

  • 12. An appraisal of the virulence factors associated with streptococcal endocarditis.
    Manning JE, Hume EB, Hunter N, Knox KW.
    J Med Microbiol; 1994 Feb 22; 40(2):110-4. PubMed ID: 8107058
    [Abstract] [Full Text] [Related]

  • 13. Amoxycillin-resistant oral streptococci and experimental infective endocarditis in the rabbit.
    Longman LP, Marsh PD, Martin MV.
    J Antimicrob Chemother; 1992 Sep 22; 30(3):349-52. PubMed ID: 1452500
    [Abstract] [Full Text] [Related]

  • 14. Identity of viridans streptococci isolated from cases of infective endocarditis.
    Douglas CW, Heath J, Hampton KK, Preston FE.
    J Med Microbiol; 1993 Sep 22; 39(3):179-82. PubMed ID: 8366515
    [Abstract] [Full Text] [Related]

  • 15. Reduction of the susceptibility to infective endocarditis with time in animals with endocavitary catheters.
    Pujadas-Capmany R, Permanyer-Miralda G, Foz-Sala M, Argimón-Pallás J, Rosell-Abaurrea F, Jáne-Pesquer J, Prats-Pastor G.
    Br J Exp Pathol; 1984 Dec 22; 65(6):683-90. PubMed ID: 6498085
    [Abstract] [Full Text] [Related]

  • 16. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.
    Antimicrob Agents Chemother; 2017 May 22; 61(5):. PubMed ID: 28264848
    [Abstract] [Full Text] [Related]

  • 17. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
    Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR.
    Clin Infect Dis; 2001 Aug 15; 33(4):577-9. PubMed ID: 11462199
    [Abstract] [Full Text] [Related]

  • 18. Effective oral health in infective endocarditis: efficacy of high-street mouthwashes against the viridans group streptococci.
    Elshibly A, Coulter WA, Millar BC, Prendergast BD, Thornhill M, Irwin C, Goldsmith CE, Moore JE.
    J Investig Clin Dent; 2014 May 15; 5(2):151-3. PubMed ID: 24610586
    [Abstract] [Full Text] [Related]

  • 19. Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis.
    Muñoz P, Giannella M, Scoti F, Predomingo M, Puga D, Pinto A, Roda J, Marin M, Bouza E, Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital (GAME).
    Clin Microbiol Infect; 2012 Mar 15; 18(3):293-9. PubMed ID: 21733030
    [Abstract] [Full Text] [Related]

  • 20. Platelet-streptococcal interactions in endocarditis.
    Herzberg MC.
    Crit Rev Oral Biol Med; 1996 Mar 15; 7(3):222-36. PubMed ID: 8909879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.